British pharmaceutical giant AstraZeneca on Friday announced plans to invest $2.5 billion in China, despite the detention ...

Massive rallies broke out in Seoul Saturday as supporters and opponents of South Korean President Yoon Suk Yeol took to the ...

British pharmaceutical giant AstraZeneca signed a landmark agreement on Friday to invest 2.5-billion U.S. dollars in Beijing over the next five ...

AstraZeneca said on Friday it will spend Ksh.323 billion on a research and development hub in Beijing, as the drugmaker ...

Here are some of the major companies whose stocks moved on the week's news. The CEO aimed to excite employees and investors about futuristic, if unproven, lines of business Tesla will pursue, ...

In a bold move to cement its foothold in China’s booming biopharmaceutical sector, AstraZeneca announced Friday a $2.5 billion investment in Beijing over the next five years. The pharmaceutical titan ...

AstraZeneca has announced a $2.5 billion investment in a research and development hub in Beijing, underscoring its commitment ...

The pharma is spending $2.5 billion on an R&D center in Beijing. Elsewhere, Adaptimmune warned it could run out of cash and Pfizer sold its remaining stake in Haleon.

The largest of the collaborations is a potentially more than $4.68 billion partnership with Shanghai-based Harbour BioMed to discover and develop next-generation multi-specific antibodies for ...

AstraZeneca announced on Friday an investment of $2.5 billion in Beijing to establish the pharmaceutical company's sixth ...

BEIJING -- British pharmaceutical giant AstraZeneca signed a landmark $2.5-billion agreement on Friday to invest in Beijing ...

AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational ...